(2.5mg) Letrozole '''"

Letrozole (2.5mg)
LETROZONE is a medication primarily used in the treatment of breast cancer in postmenopausal women. LETROZONE belongs to a class of drugs called aromatase inhibitors. Aromatase is an enzyme responsible for converting androgens (male hormones) into estrogen (female hormones) in the body. In postmenopausal women, most of the estrogen is produced by this conversion process in peripheral tissues, such as fat cells. Breast cancers that are hormone receptor-positive (estrogen receptor-positive or progesterone receptor-positive) depend on estrogen to grow.
LETROZONE works by inhibiting the activity of aromatase, thereby reducing the production of estrogen in the body. This reduction in estrogen levels can slow down or inhibit the growth of hormone-sensitive breast cancers.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/letrozone-2-5-133664